Related Experiment Videos
Immune status in ataxia telangiectasia
1Department of Immunopathology, Postgraduate Institute of Medical Education & Research, Chandigarh.
The Indian Journal of Medical Research
|June 1, 1991
Summary
This study investigated the immune status of children with ataxia telangiectasia, finding common T-cell deficiencies and IgA defects. Despite immune abnormalities, patients showed normal responses to certain challenges and no malignancies.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Ataxia telangiectasia (AT) is a rare genetic disorder affecting multiple systems, including the immune system.
- Understanding immune dysregulation in AT is crucial for patient management and prognosis.
Purpose of the Study:
- To comprehensively assess the immune status of pediatric patients diagnosed with ataxia telangiectasia.
- To identify specific immune deficiencies and functional abnormalities in AT patients.
Main Methods:
- Studied the immune status of 22 AT patients over 8 years.
- Assessed T-cell counts, responses to phytohemagglutinin (PHA) and BCG antigen, immunoglobulin (IgM, IgA) levels, and NBT reduction.
- Evaluated Candida killing capacity.
Main Results:
- 14 of 19 patients had low T-cell numbers, but normal PHA response and positive BCG migration inhibition.
- IgM defects in 2/18 patients; IgA deficiency in 10/18 patients, with absent salivary IgA.
- Four children exhibited high spontaneous NBT reduction; normal Candida killing in all patients.
- No patients presented with lymphoma, leukemia, or other malignancies.
Conclusions:
- Ataxia telangiectasia patients frequently exhibit T-cell lymphopenia and significant IgA deficiency.
- Despite immune deficits, key cellular and humoral immune functions remain largely intact.
- Central nervous system (CNS) manifestations are the primary clinical presentation, with a low incidence of severe infections in this cohort.